Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02616705 · ClinicalTrials.gov registry record

Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
511
Enrollment target

NCT02616705: Completed study, sponsored by Mayo Clinic.

NCT02616705 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 511 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02616705 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
511 participants
Enrollment target

Study Summary

Immunoglobulin G4-related disease (IgG4-RD) is an uncommon inflammatory disorder that may affect multiple organ systems, including the biliary tree. IgG4-sclerosing cholangitis (IgG4-SC) can be difficult to distinguish from primary sclerosing cholangitis (PSC) or cholangiocarcinoma (CCA). The investigators aim to evaluate the sensitivity and specificity of bile for the diagnosis of IgG4-SC. Bile samples of patients with biliary strictures of various causes, including IgG4-SC, PSC, and CCA, will be collected during clinical cholangiography procedures. IgG4 will be measured in bile specimens and bile IgG4 concentrations compared between IgG4-SC, PSC, CCA, and other types of biliary strictures.

Primary Outcome

Bile concentration of IgG4 will be measured in cases and controls, and the groups will be compared using appropriate statistical methods

Trial Details

FieldValue
Enrollment Target 511 participants
Start Date 2015-11
Est. Completion 2019-09-30
Mayo Clinic

2,844 total trials

What the finished NCT02616705 record still lists

NCT02616705 is an observational study that tracks outcomes without assigning an intervention. The registered 511 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02616705 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02616705 about?

NCT02616705 is a clinical study titled "Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis". Immunoglobulin G4-related disease (IgG4-RD) is an uncommon inflammatory disorder that may affect multiple organ systems, including the biliary tree. IgG4-sclerosing cholangitis (IgG4-SC) can be difficult to distinguish from primary sclerosing cholangitis (PSC) or cholangiocarcinoma (CCA). The invest...

What is the current status of trial NCT02616705?

This trial is currently completed. The enrollment target is 511 participants. The study started on 2015-11. Estimated completion is 2019-09-30.

Who is sponsoring clinical trial NCT02616705?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05005403 · 512 participants · Phase 1

    Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab

  • NCT05337410 · 512 participants · NA

    YES: Innovative Discussion for Engagement, Achievement, and Service

  • NCT06096259 · 512 participants · Phase 2

    Preventing Injured Knees From osteoArthritis: Severity Outcomes

  • NCT03922542 · 510 participants · Phase 2

    Comparison of Standard vs. Accelerated Corneal Crosslinking

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02616705, the US trial registry maintained by the National Library of Medicine. NCT02616705 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.